Key facts
- This page summarizes Cathy Klema's Form 4 filing for OptimizeRx Corp (OPRX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 04 Feb 2025, 18:50.
Cathy Klema - 02 Feb 2025 Form 4 Insider Report for OptimizeRx Corp (OPRX)
- Reporting relationship
- Director
- Issuer ticker
- OPRX
- Reported as of
- 02 Feb 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 04 Feb 2025, 18:50:31 UTC
- Prior SEC filing
- 11 Jun 2024
- Next SEC filing
- 12 Jun 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Marion Odence-Ford, by Power of Attorney
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Cathy Klema filed Form 4 for OptimizeRx Corp (OPRX) on 04 Feb 2025.
Change
- Previous filing in this sequence was filed on 11 Jun 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OPRX
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +5,109
- Change %
- +77%
- Price
- $0.000000
- Shares after
- 11,752
- Date
- 02 Feb 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OPRX
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -5,109
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 02 Feb 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,109
- Exercise price
- Footnotes
- F1, F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Restricted stock units convert into common stock on a one-for-one basis.
Footnote F2
The restricted stock units vested in full on February 2, 2025, the first anniversary of the date of grant.
SEC remarks
The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person.